Cheetham, S C <br/><br/>
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.  [electronic resource] 

 -  Neuropharmacology  Aug 2000 
 - 2028-35 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/s0028-3908(00)00032-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Appetite Depressants--pharmacology<br/>Brain--drug effects<br/>Cyclobutanes--pharmacology<br/>Dexfenfluramine--antagonists & inhibitors<br/>Fluoxetine--pharmacology<br/>Male<br/>Paroxetine--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Serotonin Receptor Agonists--pharmacology<br/>Selective Serotonin Reuptake Inhibitors--pharmacology